Literature DB >> 8136742

Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia in first complete remission: factors predictive of transplant-related mortality and influence of total body irradiation modalities.

L Sutton1, M Kuentz, C Cordonnier, D Blaise, A Devergie, D Guyotat, V Leblond, M Flesch, P Bordigoni, M Attal.   

Abstract

In a retrospective multicentre study, we analyzed 184 consecutive patients who underwent bone marrow transplantation (BMT) from identical siblings for adult acute lymphoblastic leukemia in first complete remission between March 1980 and May 1989. The main causes of transplant-related mortality were GVHD and interstitial pneumonitis. Univariate and multivariate analyses identified the mode of total body irradiation (TBI) as the only independent predictive factor of transplant-related mortality. Ninety-one patients received single-dose TBI and 93 received fractionated-dose TBI as part of the conditioning regimen prior to BMT. Transplant-related mortality was more frequent in the single dose group (p = 0.017). The incidence of interstitial pneumonitis, acute and chronic GVHD and veno-occlusive disease of the liver was not statistically different between the two irradiation groups. However, fatal interstitial pneumonitis was significantly more frequent in the single dose irradiation group (p = 0.031). These results show that transplant-related mortality is closely associated with the mode of TBI administration. The increased relapse rate in the fractionated group explains why there was no difference between the two groups in terms of overall leukemia-free survival.

Entities:  

Mesh:

Year:  1993        PMID: 8136742

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  10 in total

Review 1.  Biology and treatment of adult acute lymphoblastic leukemia.

Authors:  L Levitt; R Lin
Journal:  West J Med       Date:  1996-02

2.  Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results.

Authors:  Partow Kebriaei; Roland Bassett; Genevieve Lyons; Ben Valdez; Celina Ledesma; Gabriela Rondon; Betul Oran; Stefan Ciurea; Amin Alousi; Uday Popat; Krina Patel; Sairah Ahmed; Amanda Olson; Qaiser Bashir; Nina Shah; Roy Jones; David Marin; Katayoun Rezvani; Yago Nieto; Issa Khouri; Muzaffar Qazilbash; Chitra Hosing; Elizabeth Shpall; Richard E Champlin; Borje S Andersson
Journal:  Biol Blood Marrow Transplant       Date:  2016-11-02       Impact factor: 5.742

3.  Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALL.

Authors:  P Kebriaei; T Madden; X Wang; P F Thall; C Ledesma; M de Lima; E J Shpall; C Hosing; M Qazilbash; U Popat; A Alousi; Y Nieto; R E Champlin; R B Jones; B S Andersson
Journal:  Bone Marrow Transplant       Date:  2012-06-25       Impact factor: 5.483

4.  Clofarabine combined with busulfan provides excellent disease control in adult patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation.

Authors:  Partow Kebriaei; Roland Basset; C Ledesma; S Ciurea; S Parmar; E J Shpall; C Hosing; Issa Khouri; M Qazilbash; U Popat; A Alousi; Y Nieto; R B Jones; M de Lima; R E Champlin; Borje S Andersson
Journal:  Biol Blood Marrow Transplant       Date:  2012-06-29       Impact factor: 5.742

5.  Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.

Authors:  Partow Kebriaei; Claudio Anasetti; Mei-Jie Zhang; Hai-Lin Wang; Ibrahim Aldoss; Marcos de Lima; H Jean Khoury; Brenda M Sandmaier; Mary M Horowitz; Andrew Artz; Nelli Bejanyan; Stefan Ciurea; Hillard M Lazarus; Robert Peter Gale; Mark Litzow; Christopher Bredeson; Matthew D Seftel; Michael A Pulsipher; Jaap-Jan Boelens; Joseph Alvarnas; Richard Champlin; Stephen Forman; Vinod Pullarkat; Daniel Weisdorf; David I Marks
Journal:  Biol Blood Marrow Transplant       Date:  2017-12-25       Impact factor: 5.742

6.  Total-body irradiation before bone marrow transplantation for acute leukemia in first or second complete remission. Results and prognostic factors in 326 consecutive patients.

Authors:  Y Belkacémi; F Pène; E Touboul; B Rio; V Leblond; N C Gorin; A Laugier; C Gemici; M Housset; M Ozsahin
Journal:  Strahlenther Onkol       Date:  1998-02       Impact factor: 3.621

Review 7.  Pulmonary Toxicity After Total Body Irradiation - Critical Review of the Literature and Recommendations for Toxicity Reporting.

Authors:  Jennifer Vogel; Susanta Hui; Chia-Ho Hua; Kathryn Dusenbery; Premavarthy Rassiah; John Kalapurakal; Louis Constine; Natia Esiashvili
Journal:  Front Oncol       Date:  2021-08-26       Impact factor: 6.244

8.  Once-a-day fractionated total-body irradiation: A regimen tailored to local logistics in allogeneic stem cell transplantation for acute lymphoblastic leukemia.

Authors:  Nour Ben Abdeljelil; Saloua Ladeb; Talel Dahmani; Lotfi Kochbati; Amel Lakhal; Rym El Fatmi; Lamia Torjemane; Dorra Belloumi; Mounir Besbes; Farouk El Benna; Chiraz Nasr Ben Ammar; Tarek Ben Othman
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-28

9.  Total body irradiation and pneumonitis risk: a review of outcomes.

Authors:  S A Carruthers; M M Wallington
Journal:  Br J Cancer       Date:  2004-06-01       Impact factor: 7.640

10.  Busulfan-containing conditioning regimens in allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia: A Taiwan observational study.

Authors:  Yu-Hung Wang; Feng-Ming Tien; Cheng-Hong Tsai; Huai-Hsuan Huang; Jia-Hau Liu; Xiu-Wen Liao; Jih-Luh Tang; Ming Yao; Bor-Sheng Ko
Journal:  Cancer Rep (Hoboken)       Date:  2021-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.